Curebase’s Enhanced Telemedicine Feature Expands Patient Access to Edesa Biotech Derm Study

Curebase’s Enhanced Telemedicine Feature Expands Patient Access to Edesa Biotech Derm Study

Caption Health Adds Virtual Health Exec to Board to Help Reshape Cardiac Ultrasound Market

Caption Health is announcing that Joe DeVivo, President of Hospitals and Health Systems at Teladoc Health, is joining its board of directors. Mr. DeVivo will share his expertise in Med Tech and Health Tech, gleaned over decades in the industry, to help guide the company on its mission to democratize access to high-quality ultrasounds.

RefleXion Receives Breakthrough Device Designation for Lung Cancer Treatment

RefleXion Medical, Inc., has been granted FDA Breakthrough Device Designation for its biology-guided radiotherapy (BgRT) for use in treating lung tumors. The breakthrough potential of BgRT lies in its ability to detect and then immediately treat multiple moving tumors. It is the first and only technology to use injected radiotracers to produce active signals, called emissions, from each tumor to guide treatment delivery.

Global pharma industry gathers at CPhI Worldwide 2021 as surge in partnering expected in 2022

Global Multi-Omics Market Research Report – Collective Technologies that are Defining a New Era for Integrative Medicine

The next phase of market growth is likely to be driven by rising demand for personalized medicine, technological advancements, favourable funding environment, growing incidence of cancer & genetic disorders.

Pistoia Alliance predicts a focus on the fight against antimicrobial resistance and a surge in quantum computing research for 2022

Innovation experts Linda Kasim, Imran Haq and Anca Ciobanu share predictions for innovation in life sciences for the year ahead

Boehringer Ingelheim signs two-year license deal with Qlucore

BOC RNA Expands Its Oligo Synthesis Services for Biomedical Research

InsightRX’s Precision Medicine Technology to Help Improve Care for Patients Receiving Stem Cell Transplants

InsightRX’s Precision Medicine Technology to Help Improve Care for Patients Receiving Stem Cell Transplants

Stilla Technologies secures financing of more than €31 million adding Casdin Capital and the European Investment Bank to existing investors

Stilla Technologies, the multiplex digital PCR company, has secured more than €31 million in new financing, adding Casdin Capital and the European Investment Bank (EIB) in addition to new funding from existing investors Illumina Ventures, Kurma Partners, TusPark Capital Management (Luxembourg) S.à r.l., LBO France, BNP Paribas Développement, and Eurazeo.

Applied BioMath, LLC Awarded Top Biosimulation Solution Company by Pharma Tech Outlook

Applied BioMath, the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), was listed as one of the top ten biosimulation solution companies for 2021 by Pharma Tech Outlook.

MDI Biological Laboratory Scientist Advances Prospect of Regeneration in Humans

In a study that builds on earlier research that identified macrophages as essential to regeneration in the axolotl, a highly regenerative salamander, James Godwin, Ph.D., a scientist at the MDI Biological Laboratory in Bar Harbor, Maine, has identified the source of these critical white blood cells as the liver. By giving scientists a place to look for pro-regenerative macrophages in humans, the discovery brings science a step closer to being able to regenerate tissues and organs lost to injury or disease in humans.

Rebeca Sanchez Sarmiento joins Insightful Science and Dotmatics as Chief Financial Officer

Watson-Marlow Fluid Technology Group Crowned Most Innovative Pharma Fluid Management Solutions Provider 2021 Status message

Watson-Marlow Fluid Technology Group announces it has been named Most Innovative Pharma Fluid Management Solutions Provider 2021 at the Global Health and Pharma Healthcare and Pharmaceutical Awards.

Life Science Technology Visionary Steve Rosenberg Joins Anju Software's Board of Directors

Anju Software has announced that Steve Rosenberg, an industry leader and innovator in developing and deploying patient-centric clinical trial technologies, has joined the company's Board of Directors. Rosenberg also formerly led Oracle's clinical software business.

CD Formulation Assists in Solving Dosage Form Development Problems

T,C&A Lab Offers Glass Testing to Reduce Risk and Validate Glass Performance

New hope for bowel cancer patients as fresh partnership between Carina Biotech and CellVec enables advancement of clinical trials.

Singapore-based viral vector CDMO CellVec announces today that it has been selected as the manufacturer of choice for Australian cell therapy immuno-oncology company Carina Biotech, undertaking the production of GMP-compliant lentivirus constructs for its LGR5 CAR-T. The partnership is slated to advance clinical trials for a treatment designed for patients with advanced colorectal (bowel) cancer.

New Executive Appointments Position physIQ for Further Strategic Growth and Market Expansion

Pharma veteran Mike Petrarca joins physIQ to drive revenue growth in the life sciences continuum; Chris Economos to advance strategic partnerships

Pure Storage FlashArray Enables TrialStat to Offer Clinical Trial Researchers 300 Times Faster Access to Data

Pure's Evergreen Storage subscription allows TrialStat to upgrade its storage with no disruptions